Johnson And Johnson News - JNJ

Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results

NEW BRUNSWICK, N.J., July 7 /PRNewswire-FirstCall/ -- Johnson & Johnson will host a conference call for financial analysts at 8:30 a.m. (Eastern...

Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories

HORSHAM, Pa., June 29 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today that a federal jury has returned a verdict of $1.67 billion...

Girls' Overall Self-Worth Improves With Contact Lens Wear, Study Shows

While both boys and girls experience value-added benefits beyond vision correction, girls experience stronger boost in self esteem with switch to...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

Anti-TNF Experienced Patients Demonstrated Improvement With Every-Four-Week Subcutaneous SIMPONI Despite Previous Medication or Reason for...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriat

Long-Term Data in Patients Receiving Every-Four-Week Subcutaneous SIMPONI Presented at 2009 EULAR Annual Congress COPENHAGEN, June 9...

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Diseas

First-of-its-Kind Study Demonstrates REMICADE More Likely to Maintain Steroid-Free Remission in Patients Naive to Immunomodulators and...

Eye Related Symptoms Bring More Than Tears to Allergy Sufferers, New Survey Reveals

Free "Eye Health & Allergies" brochure available from Asthma & Allergy Foundation of America JACKSONVILLE, Fla., May 28 /PRNewswire/ -- Many...

FDA Extends Review Timeline for STELARA(TM) (ustekinumab) Biologic License Application by Three Months

HORSHAM, Pa., May 26 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today that the U.S. Food and Drug Administration (FDA) has extended...

VISTAKON(R) Launches ACUVUE(R) DIRECT(TM)

Offers more affordable, convenient way to buy annual supply of ACUVUE(R) Brand Contact Lenses JACKSONVILLE, Fla., May 13 /PRNewswire/...

Every Picture Tells A Story, Particularly for Those With Epilepsy

Expressions of Courage(R) Art Contest for People with Epilepsy Now Accepting Entries TITUSVILLE, N.J., May 11 /PRNewswire/ -- The definition of...

VISTAKON to Introduce ACUVUE(R) OASYS(TM) Brand Contact Lenses for PRESBYOPIA

First new multifocal contact lens from ACUVUE(R) in 11 years combines unique Stereo Precision Technology(TM) optics and innovative senofilcon A...

Johnson & Johnson to Webcast Annual Meeting of Shareholders

NEW BRUNSWICK, N.J., April 16 /PRNewswire-FirstCall/ -- Johnson & Johnson will webcast its Annual Meeting of Shareholders at 10 a.m. (Eastern...

Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results

NEW BRUNSWICK, N.J., April 7 /PRNewswire-FirstCall/ -- Johnson & Johnson will host a conference call for financial analysts at 8:30 a.m...

FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration

SARATOGA, Calif., March 30 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for...

Johnson & Johnson to Participate in the 29th Annual Cowen & Company Health Care Conference

NEW BRUNSWICK, N.J., March 10 /PRNewswire-FirstCall/ -- Johnson & Johnson will participate in the 29th Annual Cowen & Company Health Care...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Johnson And Johnson (JNJ)

Professional-Grade Tools, for Individual Investors.

JNJ News

Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results

Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories

Girls' Overall Self-Worth Improves With Contact Lens Wear, Study Shows

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriat

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Diseas

Eye Related Symptoms Bring More Than Tears to Allergy Sufferers, New Survey Reveals

FDA Extends Review Timeline for STELARA(TM) (ustekinumab) Biologic License Application by Three Months

VISTAKON(R) Launches ACUVUE(R) DIRECT(TM)

Every Picture Tells A Story, Particularly for Those With Epilepsy

VISTAKON to Introduce ACUVUE(R) OASYS(TM) Brand Contact Lenses for PRESBYOPIA

Johnson & Johnson to Webcast Annual Meeting of Shareholders

Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results

FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration

Johnson & Johnson to Participate in the 29th Annual Cowen & Company Health Care Conference

JNJ Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Johnson And Johnson (JNJ) News

Johnson And Johnson (JNJ)

Professional-Grade Tools, for Individual Investors.

JNJ News

Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results

Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories

Girls' Overall Self-Worth Improves With Contact Lens Wear, Study Shows

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriat

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Diseas

Eye Related Symptoms Bring More Than Tears to Allergy Sufferers, New Survey Reveals

FDA Extends Review Timeline for STELARA(TM) (ustekinumab) Biologic License Application by Three Months

VISTAKON(R) Launches ACUVUE(R) DIRECT(TM)

Every Picture Tells A Story, Particularly for Those With Epilepsy

VISTAKON to Introduce ACUVUE(R) OASYS(TM) Brand Contact Lenses for PRESBYOPIA

Johnson & Johnson to Webcast Annual Meeting of Shareholders

Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results

FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration

Johnson & Johnson to Participate in the 29th Annual Cowen & Company Health Care Conference

JNJ Discussion

Your Recent History